Analyst firms · H.C. Wainwright · BHVN

H.C. Wainwright BHVN price target and rating history

Biohaven Ltd. (BHVN) · Health Care

H.C. Wainwright rates Biohaven Ltd. (BHVN) Neutral with a $11 price target, as of its latest action on Dec 3, 2025. It has published 4 rating actions on BHVN since July 2021, including 0 upgrades and 1 downgrade. Across 6 firms with a BHVN price target in the last 12 months, the median target is $15. H.C. Wainwright's $11 is 27% below that.

Current rating
Neutral
Price target
$11
Median target, all firms
$15
Actions on BHVN
4

H.C. Wainwright price target on BHVN

$160$86$1120222023202420252026
H.C. Wainwright price target on BHVN, each point a stated target, July 2021 to December 2025.

Every H.C. Wainwright rating on BHVN

How other firms rate BHVN

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
RBC Capital MarketsSector Perform$19Sep 8, 2026
BofA SecuritiesUnderperform$11Jun 29, 2026
Canaccord GenuityBuy$21Apr 13, 2026
Goldman SachsBuy$23Feb 6, 2026
H.C. WainwrightNeutral$11Dec 3, 2025
UBSNeutral$11Nov 26, 2025

Questions about H.C. Wainwright and BHVN

What is H.C. Wainwright's price target for BHVN?
H.C. Wainwright's latest stated price target for Biohaven Ltd. (BHVN) is $11, from its action on Dec 3, 2025.
What is H.C. Wainwright's rating on BHVN?
H.C. Wainwright rates BHVN Neutral, a neutral rating, as of Dec 3, 2025.
When did H.C. Wainwright last change its view on BHVN?
On Dec 3, 2025, H.C. Wainwright downgrades to Neutral from Buy, price target $11.
How does H.C. Wainwright's BHVN target compare with other analysts?
Across 6 firms with a BHVN price target in the last 12 months, the median target is $15. H.C. Wainwright's $11 is 27% below that.

More BHVN rating histories

All H.C. Wainwright ratingsBHVN news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.